Intranasal budesonide for rhinitis during a high airborne pollution period: a randomized controlled trial.

Yuan ZhangChunguang ShanWeiwei LiuYaozhong HanGuanggang ShiYongjian MaKerstin WagnerXiaoyan TianLili ZhangAllan Joseph LaronaSteven SacavageKathleen FranklinChengshuo WangLuo Zhang

Published in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2022)

Intranasal budesonide 256 µg once daily improved the total nasal symptoms and itching/sneezing over 10 days in adults with rhinitis triggered/worsened by airborne pollution.

Keyphrases

particulate matter
air pollution
heavy metals
physical activity
risk assessment
health risk assessment
sleep quality
human health
depressive symptoms
climate change
drinking water